Smartleaf Asset Management LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 2010393 BOSTON, MA

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$450,314

-$28,058 QoQ

Shares Held

1,361

+13.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Smartleaf Asset Management LLC holds $9,124,817 across 150 Biotechnology names. ALNY ranks #4 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,540	$2,027,291
2	CAI	Caris Life Sciences, Inc.	94,051	$1,681,631
3	REGN	Regeneron Pharmaceuticals, Inc.	846	$653,653
4	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,361	$450,314
5	ARGX	Argenx SE	463	$338,105
6	ALLO	Allogene Therapeutics, Inc.	137,874	$336,412
7	INSM	INSMED Inc	1,747	$285,669
8	TECH	BIO-TECHNE Corp	4,639	$242,434

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$450,314	1,361	+13.1%	Shares	Sole	2026-05-15
2025-12-31	$478,372	1,203	+11.7%	Shares	Sole	2026-02-13
2025-09-30	$491,112	1,077	+81.3%	Shares	Sole	2025-11-05
2025-06-30	$193,697	594	-33.6%	Shares	Sole	2025-08-14
2025-03-31	$241,667	895	+19.8%	Shares	Sole	2025-05-14
2024-12-31	$175,776	747	+69.4%	Shares	Sole	2025-02-05
2024-09-30	$121,288	441	+283.5%	Shares	Sole	2024-11-13
2024-06-30	$27,945	115	+1050.0%	Shares	Sole	2024-10-08
2024-03-31	$1,494	10	—	Shares	Sole	2024-10-07
No filing history on record for this holder in this stock.